Profil
In addition to joining CentreStone in 2006, Mr. Sheedy played a key role in preparing DiaMedica for its IPO in 2007.
He also worked to secure a license agreement with HealthPartners Research Foundation on behalf of Sanomune and has helped prepare documentation for grant applications and several clinical trials.
Mr. Sheedy is a graduate of the University of Manitoba’s Asper School of Business as well as the WestLink Technology Commercialization Internship Program.
Anciens postes connus de Mat Sheedy
| Sociétés | Poste | Fin |
|---|---|---|
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone is an active manager which invests in life sciences companies located in western Canada and the US Midwest region. It participates in early stage capital requirements. | Analyste en capital-investissement | 31/01/2010 |
| DIAMEDICA THERAPEUTICS INC. | Public Communications Contact | - |
Formation de Mat Sheedy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone is an active manager which invests in life sciences companies located in western Canada and the US Midwest region. It participates in early stage capital requirements. | Finance |
















